Nandini and Peter symbolize a modern power couple, contributing significantly to the Piramal Group’s dynamic and forward-looking vision.

Market regulator Securities and Exchange Board of India (SEBI) has cleared Piramal Pharma Ltd (PPL) of allegations concerning ...

Piramal Pharma Share Price: Brokerage firm Jefferies is positive on the shares of Piramal Pharma Limited. The pharma company announced its results for the quarter ended on September 30 ...

Till 12:35 pm; a combined 32.3 million shares representing 2.43 per cent of total equity of PPL changed hands on the NSE and BSE.

Piramal Pharma's company's revenue for the quarter under review stood at Rs 2,242 crore as compared to Rs 1,911 crore which implies an increase of 17 per cent Y-o-Y ...

Piramal Pharma (PPL) has been exonerated in a case related to alleged non-disclosure of material information to the ...

Piramal Pharma Ltd released its fiscal second quarter earnings with profit at Rs 22.59 crore. (Image Source: Unsplash) Piramal Pharma Ltd on Wednesday released its fiscal second quarter earnings ...

Piramal Pharma Ltd share price was down by -4.21% from the previous closing price of ₹281.55. Who are peers of Piramal Pharma Ltd? The peers of Piramal Pharma Ltd are Sun Pharmaceuticals ...

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global ...

Chennai: Pharma market reported better revenue growth in Q2 FY25 against the year-ago quarter, mainly driven by price rise ...

The Securities and Exchange Board of India (SEBI) on November 8 cleared Piramal Pharma Limited (PPL) of allegations ...